Center for Substance Abuse Treatment; Notice of Meeting, 32952-32953 [2021-13132]

Download as PDF 32952 Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices jbell on DSKJLSW7X2PROD with NOTICES and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: SBIR/STTR Commercialization Readiness Pilot (CRP) Program. Date: July 15, 2021. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Allen Richon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301–379– 9351, allen.richon@nih.hhs.gov. Name of Committee: Infectious Diseases and Immunology B Integrated Review Group; HIV Coinfections and HIV Associated Cancers Study Section. Date: July 15, 2021. Time: 9:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3196, Bethesda, MD 20892, 301–451–5953, tuoj@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowship: Infectious Diseases and Immunology Panel C. Date: July 15–16, 2021. Time: 9:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shahrooz Vahedi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 810G, Bethesda, MD 20892, (301) 496–9322, vahedis@mail.nih.gov. Name of Committee: Infectious Diseases and Immunology B Integrated Review Group; HIV Immunopathogenesis and Vaccine Development Study Section. Date: July 15–16, 2021. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shiv A. Prasad, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892, 301–443– 5779, prasads@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Reproductive Biology. VerDate Sep<11>2014 17:13 Jun 22, 2021 Jkt 253001 Date: July 16, 2021. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Yunshang Piao, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, Bethesda, MD 20892, (301) 402–8402, piaoy3@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Infectious Diseases and Immunology Research Enhancement Review. Date: July 19, 2021. Time: 9:30 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Liangbiao Zheng, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD 20892, 301–996– 5819, zhengli@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Human Complex Mental Function. Date: July 19, 2021. Time: 1:00 p.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Pamela Jeter, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 10J08, Bethesda, MD 20892, (301) 435–2591, pamela.jeter@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in infectious diseases vaccines, therapeutics and vector biology. Date: July 20, 2021. Time: 9:30 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, RM 3200, MSC 7808, Bethesda, MD 20892, 301–435– 1167, pandyaga@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 17, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–13184 Filed 6–22–21; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment (CSAT) National Advisory Council (NAC) will meet on August 12, 2021, 1:00 p.m.–4:30 p.m. (EDT). The meeting is open to the public and will include consideration of minutes from the SAMHSA CSAT NAC meeting of March 31, 2021; an update on CSAT activities; a discussion with SAMHSA leadership; and discussion of recovery and recovery support. Interested persons may present data, information, or views, orally or in writing, on issues pending before the Council. Written submissions should be forwarded to the contact person on or before August 6, 2021. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations must notify the contact person on or before August 6, 2021. Five minutes will be allotted for each presentation. The meeting will be conducted via WebEx and telephone only, and registration is required to participate during this me. To attend virtually, or to obtain the call-in number and access code, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register on-line at https://snacregister.samhsa.gov/ MeetingList.aspx, or communicate with the CSAT National Advisory Council Designated Federal Officer; Tracy Goss (see contact information below). Meeting information and a roster of Council members may be obtained by accessing the SAMHSA Committee website at https://www.samhsa.gov/ about-us/advisory-councils/csatnational-advisory-council or by contacting the CSAT National Advisory Council Designated Federal Officer. Council Name: SAMHSA’s Center for Substance Abuse Treatment National Advisory Council. Date/Time/Type: August 12, 2021, 1:00 p.m.–4:30 p.m. EDT, OPEN. Place: SAMHSA, 5600 Fishers Lane, Rockville, Maryland 20857. Contact: Tracy Goss, Designated Federal Officer, CSAT National Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail), E:\FR\FM\23JNN1.SGM 23JNN1 Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices Telephone: (240) 276–0759, Email: tracy.goss@samhsa.hhs.gov. Dated: June 16, 2021. Carlos Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2021–13132 Filed 6–22–21; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY [Docket No. CISA–2021–0003] Notice of Request for Revision of a Currently Approved Information Collection for the Chemical Facility Anti-Terrorism Standards (CFATS) Cybersecurity and Infrastructure Security Agency, DHS. ACTION: 30-Day notice and request for comments; revision of Information Collection Request: 1670–0014. AGENCY: Authority: 6 U.S.C. 621–629. The Infrastructure Security Division (ISD) within the Cybersecurity and Infrastructure Security Agency (CISA) is issuing a 60-day notice and request for comments to revise Information Collection Request (ICR) 1670–0014. CISA will submit the ICR to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. DHS previously published this information collection request (ICR), in the Federal Register, on Monday, March 23, 2021 at 86 FR 15490 for a 60-day public comment period. No comments was/were received by DHS. To access and review all documents related to this information collection, please visit the Federal eRulemaking Portal site at https://www.regulations.gov and enter Docket Number CISA–2021–0003 in the search box. The purpose of this notice is to allow an additional 30 days for public comments. DATES: Comments are encouraged and will be accepted until August 23, 2021. ADDRESSES: You may submit comments, identified by docket number CISA– 2021–0003 through the Federal eRulemaking Portal available at https:// www.regulations.gov. Follow the instructions for submitting comments. Instructions: All comments received via https://www.regulations.gov will be posted to the public docket at https:// www.regulations.gov, including any personal information provided. Do not submit comments that include trade secrets, confidential commercial or financial information, Chemicalterrorism Vulnerability Information jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:13 Jun 22, 2021 Jkt 253001 (CVI), Protected Critical Infrastructure Information (PCII), or Sensitive Security Information (SSI) directly to the public regulatory docket. Contact the individual listed in the FOR FURTHER INFORMATION CONTACT section below with questions about comments containing protected information. CISA will not place comments containing protected information in the public docket and will handle them in accordance with applicable safeguards and restrictions on access. Comments containing protected information will be held in a separate file to which the public does not have access and CISA will place a note in the public docket documenting receipt of the comment. If CISA receives a request to examine or copy this information, CISA will treat it as any other request under the Freedom of Information Act (FOIA), 5 U.S.C. 552, and the Department’s FOIA regulation found in part 5 of Title 6 of the Code of Federal Regulations (CFR). FOR FURTHER INFORMATION CONTACT: Lona Saccomando, 703–235–5263, CISARegulations@cisa.dhs.gov. SUPPLEMENTARY INFORMATION: The CFATS Program identifies chemical facilities of interest and regulates the security of high-risk chemical facilities through a risk-based approach. The CFATS Program is authorized under the Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2014 1 or ‘‘CFATS Act of 2014’’. CISA collects necessary information through 1670–0014 to implement CFATS. CISA’s Methodology in Estimating the Burden for the Request for Redetermination This instrument collects information to support a facility’s request for redetermination of high-risk which CISA is obligated to perform pursuant to the CFATS Act of 2014. The collection of information may be concurrent with a facility’s submission of a Top-Screen pursuant to 6 CFR 27.210(d) or collected after CISA reviews a Top-Screen that reflects material modifications made by the facility. This instrument authorizes CISA to collect both the reason for the redetermination as well as supporting documentation. CISA is proposing minor revisions to the instrument that reflect the passage of the Cybersecurity and Infrastructure Security Act of 2018, 6 U.S.C. 651–74, such as updating the Agency name to 1 The Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2014 (also known as the CFATS Act of 2014, Pub. L. 113–254) codified the CFATS program into the Homeland Security Act of 2002. See 6 U.S.C. 621 et seq., as amended by Public Law 116–136, Sec. 16007 (2020). PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 32953 conform with the Agency’s new designation as CISA, as well as a clearer description of the scope of the instrument. The scope of this instrument remains unchanged. Number of Respondents The current information collection estimated that 625 respondents would submit a request for a Request for Redetermination annually. Based on data collected between CY 2018–2020, 215 respondents, on average, submitted a Request for Redetermination annually. Because of the historical pattern of lower submissions over the past three years, CISA proposes to decrease the estimated number of respondents from 625 to 250 respondents. CISA will retain the number of responses per respondent of 1.0. Estimated Time per Respondent In the current information collection, the estimated time per respondent to prepare and submit a Request for Redetermination is 0.25 hours (15 minutes). CISA continues to believe this is a reasonable burden estimate for this instrument. Annual Burden Hours The annual burden hours for a Request for Redetermination is [0.25 hours × 250 respondents × 1 response per respondent], which equals 62.5 hours. Total Capital/Startup Burden Cost CISA provides access to CSAT free of charge and assumes that each respondent already has computer hardware and access to the internet for basic business needs. Therefore, there are no annualized capital or start-up costs incurred by chemical facilities of interest or high-risk chemical facilities for this information collection. Total Recordkeeping Burden There are no recordkeeping burden costs incurred by chemical facilities of interest or high-risk chemical facilities for this information collection.2 Total Annual Burden Cost CISA assumes that Site Security Officers (SSOs) are responsible for submitting a Request for Redetermination. For the purpose of this notice, CISA maintains this assumption. Therefore, to estimate the total annual burden, CISA multiplied the annual burden of 62.5 hours by the average hourly wage rate of SSOs which is 2 The recordkeeping burden for facilities under CFATS is accounted for by CISA under the CSAT Information Collection No. 1670–0007. E:\FR\FM\23JNN1.SGM 23JNN1

Agencies

[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Pages 32952-32953]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13132]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Treatment; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Treatment (CSAT) National Advisory Council 
(NAC) will meet on August 12, 2021, 1:00 p.m.-4:30 p.m. (EDT).
    The meeting is open to the public and will include consideration of 
minutes from the SAMHSA CSAT NAC meeting of March 31, 2021; an update 
on CSAT activities; a discussion with SAMHSA leadership; and discussion 
of recovery and recovery support. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the Council. Written submissions should be forwarded to the contact 
person on or before August 6, 2021. Oral presentations from the public 
will be scheduled at the conclusion of the meeting. Individuals 
interested in making oral presentations must notify the contact person 
on or before August 6, 2021. Five minutes will be allotted for each 
presentation.
    The meeting will be conducted via WebEx and telephone only, and 
registration is required to participate during this me. To attend 
virtually, or to obtain the call-in number and access code, submit 
written or brief oral comments, or request special accommodations for 
persons with disabilities, please register on-line at https://snacregister.samhsa.gov/MeetingList.aspx, or communicate with the CSAT 
National Advisory Council Designated Federal Officer; Tracy Goss (see 
contact information below).
    Meeting information and a roster of Council members may be obtained 
by accessing the SAMHSA Committee website at https://www.samhsa.gov/about-us/advisory-councils/csat-national-advisory-council or by 
contacting the CSAT National Advisory Council Designated Federal 
Officer.
    Council Name: SAMHSA's Center for Substance Abuse Treatment 
National Advisory Council.
    Date/Time/Type: August 12, 2021, 1:00 p.m.-4:30 p.m. EDT, OPEN.
    Place: SAMHSA, 5600 Fishers Lane, Rockville, Maryland 20857.
    Contact: Tracy Goss, Designated Federal Officer, CSAT National 
Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail),

[[Page 32953]]

Telephone: (240) 276-0759, Email: [email protected].

    Dated: June 16, 2021.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2021-13132 Filed 6-22-21; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.